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While most antigens capable of inducing antibody responses can, under appropriate 
conditions,  also  induce  delayed  reactivity,  some  substances  are  preeminently  in- 
vokers of  delayed hypersensitivity while they  induce  antibody synthesis poorly or 
not at all. Generally these are small molecular entities, or larger molecules that may 
be  only partially recognized as  "foreign"  by  the  responder.  Examples  of  the  first 
are  arsenobenzoate-N-acetyl tyrosine  (1)  and  small  synthetic  peptide  copolymers 
of tyrosine and glutamic acid (2). In both of these cases, expanding their molecular 
size and complexity decreases their efficacy as inducers of delayed reactivity, while 
improving  their  capacities to  induce  antibodies.  Examples  of  the  second  kind  are 
gelatin  (3),  slightly altered homologous serum  proteins  (4),  and  a  peptide derived 
from  adrenocorticotropin (ACTH)  (5),  all of which  induce good  delayed reactivity 
and  poor  antibody synthesis.  Delayed contact  hypersensitivity resulting  from  the 
spontaneous  conjugation of applied chemicals (haptens)  with  autologous epidermal 
protein  carriers  (6,  7)  illustrates  this  point  also;  antibody  production  is  a  minor 
response in these cases. 
Complete  Freund  adjuvant,  a  water-in-oil  emulsion  containing  mycobacterial 
bodies,  stimulates  the  development  of  delayed reactivity to  antigens  incorporated 
in it. This activity of mycobacteria in favoring a  delayed cellular response has been 
related to a  glycolipopeptide of the cell wall (8,  9).  Mycobacteria or their glycolipo- 
peptides elicit the appearance of epithelioid cells, which presumably arise from macro- 
phages. In the process of transforming to the epithelioid cell, the macrophage under- 
goes "activation" characterized by an increase in numbers of lysosomes and a greater 
propensity for phagocytosis (10,  11).  Such  activated  macrophages may  have a  role 
in  processing,  i.e.  digesting, macromoletular antigens  to  fragments which,  like the 
small  molecular  compounds  mentioned,  are  particularly  apt  in  inducing  delayed 
reactivity, but are poor as stimuli for the antibody response. 
The thought  that smaller structures possibly containing only single immunogenic 
determinants may be better inducers of delayed reactivity than are multideterminant 
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molecules  coincides  with a  current concept that the antibody response may require 
two responding units. One is a thymus-derived  lymphocyte which recognizes and binds 
some determinants, and holds the molecule for interaction of another of its determi- 
nants with a second (bone marrow-derived) cell. The latter is able to respond to the 
second determinant with the production of antibody (12-14). 
The thymus-derived cell may be the effector cell for delayed hypersensitivity (15). 
If it binds the determinant of a molecule which contains no other immunogenic unit, 
then the response may be limited to that of which this cell is capable, i.e.,  delayed 
hypersensitivity. 
The circumstances that could lead to this restricted kind of response might 
be, as suggested  above, the  primary use of a small molecular immunogen as a 
sensitizing agent, or sensitization  with a larger molecule of which only restricted 
portions are immunogenic, or the conversion of a multideterminant antigen to 
simpler  fragments  through  the  increased  digestive  activities  of  activated 
macrophages. 
In order to test this last thesis, we used a system in which normal and acti- 
vated macrophages  were  allowed to  phagocytose  and digest sheep  red  blood 
cells for various periods  of  time.  The  contents of  the  disrupted macrophages 
were tested for their abilities to induce antibodies and delayed hypersensitivity. 
After  longer intervals of  digestion,  the  stimulus for  the  former  disappeared, 
while that for the latter persisted. 
Materials  and Methods 
Harvesting  of Macrophages.--Peritoneal  macrophages were obtained from randomly bred 
albino guinea pigs of either sex weighing 350-500 g. The animals were sacrificed, the  ab- 
dominal skin was reflected, and 20 ml of Hanks' basic salt solution (HBSS)  1 containing 10 
units/m] of preservative-free heparin  (Calbiochem, Los Angeles, Calif.) was pipetted  into 
the peritoneal cavity via a slit in the abdominal wall. The abdomen was gently massaged 
and the peritoneal fluid was withdrawn with a pipette.  Normal macrophages were collected 
from guinea pigs which had received no peritoneal stimulation. Activated macrophages were 
collected from the cavities or omenta of animals which had received 1.0 ml of complete Freund 
adjuvant (CFA) (Difco Laboratories, Inc., Detroit,  Mich., H37Ra,  1.0 mg/ml)  in physio- 
logical saline (1 : 1) intraperitoneally 3 or 5 days previously. 
Peritoneal cells were sl,un down at 500 rpm for 5 min in Falcon plastic tissue culture tubes 
(Falcon Plastics, Los Any,  ties, Calif.). The cells were washed with 5 ml of HBSS containing 
1% normal guinea pig serum  (GPS), 50 #g/ml sodium penicillin, 50 #g/ml streptomycin, 
and 5 #g/ml neomycin (PSN). If red cells were present they were lysed by a second washing 
in one part HBSS to two parts  distilled water. The cells were then suspended to 3 >(  106 
cells/ml in medium 199 in Hanks' solution with 15% GPS and PSN. 2 
1 Abbreviations  used in thi~ paper: BCG, bacille Calmette  Guerin; CFA, complete Freund 
adjuvant; GPS, normal guinta pig serum. HBSS, Hanks' balanced salt solution; IFA, in- 
complete Freund adjuvant; PaN, 50 #g/ml sodium penicillin, 50 #g/ml streptomycin, and 
50/zg/ml neomycin; SRBC, sheep red blood cells. 
2 All media were purchased from Grand Island Biological Company, Grand Island, N.Y. 
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Macrophages were collected from  the omentum  by separating the membrane from ad- 
herent fat and chopping it finely. The fragments were gently pipetted several times in HBSS 
with 1% GPS to release the cells. Tissue fragments were allowed to settle for 5 min and the 
supernatant was decanted for treatment as described for free peritoneal cells. 
Preparation of Sheep Erythrocytes.  Sterile sheep red blood cells (SRBC)  in Alsever's so- 
lution were washed three times in sterile physiological saline. SRBC to be used for skin testing 
were suspended at final concentrations of 2 or 5% v/v in physiological saline. The SRBC to 
be added to peritoneal cell cultures, after the three saline washings, were washed once with 
HBSS and suspended to a final concentration of 2% v/v in medium 199 with 15% GPS and 
PSN. Fresh preparations of SRBC were made for each experiment. 
Incubation of Macrophages with Sheep Red Cells.--For macrophage digestion experiments, 
2 ml of fresh cell suspension (6)<  106 cells) in a  tissue culture tube were mixed with 1 ml 
of 2% SRBC  (2)<  10 s cells). The tubes were gassed with a  5% CO~:95% air mixture and 
incubated at 37°C  on a  drum roller (1  rev/10 rain) for periods of  1 and 7 hr, and in some 
experiments for 12 and 24 hr. The tubes were then spun at 800 rpm for 10 min, and the culture 
medium was removed. The unphagocytosed SRBC were lysed by a  brief washing in HBSS 
in distilled water 1:2. The macrophages were then resuspended in 1.3 ml of HBSS containing 
antibiotics and were frozen and thawed three times. 
For studies of the uptake of SRBC by macrophages, 1.5 ml of cell suspension (4.5  X  106 
cells) was placed in Leighton tubes or small Falcon Petri dishes, 0.75 ml of 2% SRBC  (1.5 
X  108 cells)  was added,  and the mixtures were incubated in 5% COs-air for various periods. 
SRBC  and all other nonadherent cells were then washed away with saline, and the macro- 
phages were dried and fixed for 3  min in anhydrous methanol. The cells were stained with 
Wright-Giemsa and examined for ingested SRBC. 
Sensitization of Guinea Pigs.--Albino guinea pigs were injected with test substances in 
0.4 ml total volume, divided between the two hind footpads. The materials used were:  (a) 
disrupted  macrophage-SRBC  preparations mixed with water-oil  emulsion;  (b)  control in- 
jections of antigen consisting of 2%  SRBC  (4)<  107 cells)  in incomplete or complete Freund 
adjuvant; (c) numbers of SRBC estimated to be phagocytosed in the experimental mixtures, 
added to heat-inactivated macrophages or injected alone, as will be described under Results. 
Antibody Titrations.--2 ml of blood were collected from guinea pigs before skin testing, at 3 
wk after sensitization. Microhemagglutination tests were performed by 2-fold serial dilutions. 
Skin  Tests.--After  bleeding,  guinea pigs were  injected intradermally in  the flank with 
0.1  ml of 5% SRBC in saline; this concentration of cells caused little or no nonspecific ir- 
ritation. The test sites were read for diameter of thickening and erythema at 4, 24, and 48 
hr. Some sites were removed at the 24 hr reading, fixed in 10% formalin, sectioned, and stained 
with hematoxylin and eosin for histologic study. 
RESULTS 
Responses to SRBC in Incomplete and Complete Freund Adjuvant.--Patterns 
of  antibody  and  skin  responses  to  SRBC  were  established in  groups  of  seven 
animals injected with 0.4 ml of 2 %  cells in each of the adjuvants. At  21  days, 
all animals in both groups  had hemagglutinating  antibodies  (Table l,  Fig.  1). 
Undiluted normal sera were negative. 
Skin tests (Fig. 1) with 5 %  SRBC in saline elicited reactions in the incomplete 
Freund  group  which  were  at  their peak  at  4  hr,  had decreased  by  24  hr,  and 
dropped  further,  in some  cases  disappearing,  by 48  hr.  The  complete  Freund 
group  responded  with  larger  indurated  reactions  which  for  the  most  part 
showed  central necrosis.  These reactions  increased  in diameter  between 4  and MARGOT  N.  PEARSON  AND  SIDNEY  RAFa?EL  497 
24 hr,  and dropped off to some extent at 48 hr. These results are of the kind 
previously reported by Boyden (16)  and follow the general pattern seen with 
soluble antigens as well (e.g., 17). 
Responses to SRBC Ingested by Macrophages.--The cellular compositions of 
peritoneal exudates are shown in Table II. Exudates from guinea pigs which 
had  received complete Freund  adjuvant  intraperitoneally 3  or 5  days earlier 
contained many more cells than did those from normal animals. The majority 
TABLE  I 
Antibody Incidence and Mean  Titers in Guinea Pigs Receiving 2% SRBC in Incomplete or 
Complete Freund Adjuvant 
Freuud  No. of  Per cent of 
adjuvant  guinea pigs  positive  Range of  Mean 
tested  hemagglutinius  titers  titer 
Incomplete  7  100  1:4-1 : 256  76.7 
Complete  7  100  1 : 16-1 : 256  96.0 
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of the  granulocytes were eosinophiles;  these were fragile in  culture  and were 
never seen to contain phagocytosed SRBC.  ' 
Normal peritoneal cells were incubated with  SRBC for 24 hr,  and samples 
were prepared for injection into normal guinea pigs after 1, 7, and 24 hr. Each 
animal received the material from l0 s disrupted macrophages in a  volume of 
0.4 ml of water-oil emulsion. The recipients were examined for antibodies and 
delayed reactivity to SRBC 21 days later. Results are shown in Table III and 
Fig. 2. 
The 1 hr samples induced antibodies in 5 of 10 animals, with titers ranging 
from 1:32 to 1:128 (mean, 24.6). 
FIG.  1.  Skin reactions and  antibody responses of guinea pigs  to  sheep erythrocytes in 
complete (CFA) and incomplete (IFA) Freund adjuvant. 498  MACROPHAGE-DIGESTED  ANTIGEN 
After 7 hr of incubation,  2  of 10 animals responded  with  sparse  antibodies, 
and  at 24 hr the preparation failed to induce antibodies in 3 animals injected. 
The  skin  reactivities  developed  by  these  groups  are  shown  in  Fig.  2.  The 
group receiving the 1 hr sample showed a pattern suggesting Arthus reactivity, 
perhaps combined with delayed. The 7- and 24-hr samples induced reactions of 
more evident delayed type that increased in size between 4 and 24 hr. Thus, as 
immunogenicity in respect to antibody induction declined with longer periods 
TABLE II 
Cellular Composition  of Normal and Adjuvant-Induced  Peritoneal  Exudates 
Average No.  Per cent of cell composition 
Guinea pig  of cells/' 
cell donor  guinea pig  Macrophages  Lymphocytes  Granuloeytes 
Normal  16  X  106  80-90  5-15  2-5 
(occ. 65)  (occ. 30) 
3 days post  65  ;<  106  55-75  5-10  20-35 
CFA i.p. 
5 days post  89  >(  106  50-70  13-15  15-35 
CFA i.p. 
TABLE  III 
Antibody  Incidence and  Titers in  Guinea Pigs  Receiving Disrupted  Normal Peritoneal 
Macrophages Incubated with Sheep Erythroeytes 
No. of  Per cent  Range of  Mean  Incubation  guinea pigs  responding with 
period  tested  hemagglutinins  titers  titers 
(hr) 
1  10  50  32-128  24.6 
7  10  20  4-8  2.2 
24  3  0  0  0 
of intramacrophagic  residence  of the  SRBC,  the  ability  to  engender  delayed 
reactivity appeared to increase. 
Cells from guinea pigs treated  with adjuvant 3 or 5 days earlier  were tested 
after  1,  7,  or 12  hr of incubation with  SRBC. Again,  tests  for antibodies  and 
skin reactivity were made at 21 days. There were no significant differences seen 
in  the  tests  with  cells  collected  at  3  or 5  days  after  adjuvant,  whether  from 
peritoneal  exudates  or omenta.  These  results  have been  combined for discus- 
sion (Fig. 3, Table IV). 
The  1 hr  samples  induced  antibodies  in  65 %  of 21  animals,  with  titers  of 
1:2  1:32 (mean,  13.1). With the 7 hr mixture 56% of 26 animals showed titers 
in  this  same range  (mean,  11.7),  but by 12  hr none of 5  injected  guinea pigs 
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The skin reactions induced by these three incubation mixtures are shown in 
Fig. 3. The 1 hr group showed reactions of Arthus type, while the animals which 
had received the 7- and 12-hr samples revealed de~ayed-type reactivity. 
Histologic studies of skin test sites were made of members of groups that had 
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FIG. 2.  Skin reactions and antibody responses  of guinea pigs to sheep  erythrocytes di- 
gested by normal macrophages for periods of 1, 7, and 24 hr. 
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FIG. 3.  Skin reactions and antibody responses  of guinea  pigs to sheep  erythrocytes di- 
gested by adjuvant-activated macrophages for periods of 1, 7, and 12 hr. 
been sensitized with the 1 and 7-hr incubation mixtures of normal macrophages 
and SRBC. The sites were removed 24 hr after skin test injection, and stained 
with hematoxylin-eosin. The 1 hr sites showed light mononuclear infiltration of 
the dermis and a  small degree of perivascular cuffing in 1 of 5  cases; many of 
these cells were polymorphonuclears. In the 7 hr group, the dermal mononuclear 500  MACROPHAGE-DIGESTED  ANTIGEN 
infiltrate was moderately heavy, as was perivascular cuffing, in which a small 
percentage of cells were polymorphonuclears. 24-hr SRBC skin test sites from 
normal control guinea pigs showed very light deposition of mononuclear and 
polymorphonuclear cells.  These results indicate the occurrence of delayed re- 
actions in the 7 hr group, and suggest mixed Arthus and delayed reactivity in 
the 1 hr animals. 
These observations do not distinguish the influence of adjuvant-treated from 
normal macrophages in altering the immunogenic capacities of sheep erythro- 
cytes in the direction of inducing delayed hypersensitive reactivity. However, 
they do indicate that continuing intramacrophagic residence of SRBC results 
in a loss of capacity to induce antibodies and in a corresponding propensity to 
evoke delayed hypersensitivity as the major response. 
Among the questions that arose in the course of this work, one concerned the 
dose of erythrocyte material contained in disrupted macrophage preparations. 
TABLE IV 
Antibody Incidence and Mean Titers in Guinea Pigs Receiving Dbrupted Adjuvant-Exposed 
Peritoneal Macrophages Incubated with Sheep ErythrocTtes 
No. of  Per cent 
Incubation  guinea pigs  responding with  Range of  Mean 
period  tested  hemagglutinins  titers  titers 
(hr) 
1  21  65  2-32  13.1 
7  26  56  4-32  11.7 
12  5  0  0  0 
A  small number of red cells  might itself dispose the recipient to develop dis- 
cernible delayed reactivity while not giving rise to antibodies. We also wished 
to know whether  an  appropriately small dose  of erythrocytes, equal  to that 
phagocytosed,  when  incubated  with  killed macrophages might have  the  im- 
munogenic properties described; i.e., whether the disrupted cells might exert an 
adjuvant  effect (18).  For these purposes,  efforts were made  to estimate  the 
numbers of erythrocytes ingested by normal and adjuvant-activated peritoneal 
exudate cells under the conditions outlined. 
Phagocytosis  of SRBC by Macrophages  In  Vitro.--1 ml  suspensions of peri- 
toneal  exudate cells  (normal  or  adjuvant-activated)  in Leighton tubes  were 
incubated with 0.5 ml of a 2 % suspension of SRBC, and at various times cover 
slips were removed, washed, and stained. For each sampling at least 500 macro- 
phages were scored for the number of cells containing SRBC, and the number 
of these per cell (Fig. 4). Phagocytosis by normal macrophages reached 20 % at 
1 hr and this figure remained constant at 7 hr, falling off to 10 % by 12 hr. The 
average number ingested was 1.5 per phagocytosing cell. 
Cells of animals treated with complete Freund adjuvant ingested SRBC more MARGOT  N.  PEARSON  AIW~  SIDNEY  RAFFEL  501 
vigorously. 15 % of those harvested 3 days after adjuva~at treatment contained 
SRBC after 1 hr of incubation, but this number increased  to 44% at 7 hr, and 
dropped  to  15%  by 12  hr.  In cultures  of cells  from animals injected  5  days 
previously with complete Freund adjuvant, 23 % of the macrophages contained 
SRBC  at 1 hr and 70% at 7 hr. In both groups the number of SRBC per in- 
dividual  macrophage was  increased  over that  seen in  the normal;  some cells 
contained as many as 15-20 discernible erythrocytes, with an average of about 
3 per phagocytosing macrophage. 
These figures permit  only crude  estimates  of  the  numbers  of erythrocytes 
that may have been ingested and digested during the total periods before the 
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FIG.  4.  Phagocytosis of sheep erythrocytes by peritoneal macrophages from normal and 
adjuvant-treated guinea pigs. 
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12 
macrophage samples were disrupted  for injection  into  animals.  More  precise 
estimates will require the use of labeled red cells, with frequent assays of macro- 
phage contents and non-erythrocyte-bound label in supernatants.  For present 
purposes,  however,  the figure of one SRBC  per three macrophages was used. 
On  this basis, 3  X  105  SRBC  per guinea pig was used  as a  test dose;  this is 
twice the calculated number of phagocytosed erythrocytes administered to each 
animal  in  the  experimental groups.  This  dose  of  ceils  in  incomplete Freund 
adjuvant was tested in five guinea pigs; at 21 days none gave evidence of either 
antibody or skin responses. 
The same numbers of SRBC were mixed with heat-killed normal or adjuvant- 
activated peritoneal cells in concentrations  equal to those used in the experi- 502  MACROPHAGE-DIGESTED  ANTIGEN 
ments described. The cell suspensions were heated at 80°C for 30 min, and were 
judged to be inactive by their failure to take up erythrosin B. The killed macro- 
phage  suspensions  from normal  animals,  or from animals  pretreated  3  days 
earlier with adjuvant,  were mixed with  SRBC and incubated for 1 hr. These 
preparations were not washed free of SRBC, but were otherwise treated and 
injected as described for living cell preparations.  None of 11  guinea pigs  in- 
jected with these mixtures revealed antibodies or skin reactivity at 21 days. 
Similar preparations  were incubated for 7 hr.  Of  12  guinea  pigs receiving 
these mixtures,  1 animal  showed  agglutinins  to a  titer of  1:8,  and  none de- 
veloped skin reactivity. 
DISCUSSION 
The rationale for these experiments arose from the question  of how myco- 
bacterial adjuvant may influence the induction of delayed reactivity to antigens 
incorporated in  it.  There is  considerable evidence from diverse sources  that 
small molecular immunogens used as primary sensitizing agents  are  especially 
apt in evoking this reactivity (1, 2) as are homologous proteins (3-5), of which 
the immunogenic entities may be minor constituents of the molecule. 
There is evidence also that macrophages may eventually destroy the  anti- 
genicity of ingested substances insofar as their ability to induce antibody forma- 
tion is concerned (19-23),  although this is not necessarily so. These cells may 
degrade most of the antigen which they ingest, but in some cases they retain a 
small fraction of it for some time, and this is suitable for induction of antibodies 
(24-26). In fact, this retained fraction may be particularly evocative of anti- 
bodies. 
There are indications that cells from animals treated with mycobacteria are 
more  actively phagocytic than  are  normal  macrophages  (10)  and  also  more 
active enzymatically (11).  Such cells (e.g., bacille Calmette Guerin (BCG)-in- 
duced alveolar cells from rabbits) were found to be more destructive of ingested 
bacterial antigens than were oil-induced peritoneal cells when tested, after 5 hr 
of incubation, for antibody-inducing properties in mice (19). The former cells 
contained more B-glucuronidase, acid phosphatase, cathepsin, acid ribonuclease, 
and lysozyme than the latter (27). 
Thus, there is information available to support one aspect of the thesis that 
antigenic substances may be degraded  by macrophages beyond the  point  of 
usefulness as evokers of antibodies, and that this may proceed more briskly in 
cells obtained from animals that have been exposed to mycobacteria. The next 
question was whether such degraded antigens may have retained their capacity 
to  induce  delayed hypersensitivity. The results  described indicate  that  with 
sheep erythrocytes this is the case.  When red cells have been incubated/or 7- 
24 hr with macrophages in vitro, the disrupted phagocytes yield products which 
are  poor  immunogens  for  antibody induction,  but  which  can  evoke delayed 
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We have not so far found this effect on immunogens to be a more rapidly 
occurring one in cells activated by pretreatment of animals with mycobacterial 
adjuvant.  A  possible reason for this  is  in  the  time  allowed for activation of 
macrophages; 3 days after treatment of the donor with adjuvant may be too 
late, in view of the fact that animals primarily injected with antigen in adjuvant 
already show delayed skin reactivity by the 3rd or 4th day (28). Perhaps more 
important,  the intervals for sampling macrophage-antigen preparations  after 
mixing must be more frequent; differences in the effects of normal and activated 
cells may well become evident between the 1- and 7-hr periods used in this work. 
These points, and others concerned with the nature of the antigenic fragments 
recovered from digesting cells, are being pursued. 
A theoretical basis for these observations can be related to current proposals 
(12-14) that antibody induction by some antigens requires the interaction of a 
recirculating  thymus-derived  lymphocyte  with  a  bone  marrow-derived  cell 
which is the precursor of the antibody synthesizer. The first may recognize and 
bind  a  determinant  in  a  molecule,  anchoring  it  so  that  the  second cell can 
interact with another determinant to which it eventually responds with anti- 
body. If the  antigen presented to the  responding animal is  a  small molecule 
containing perhaps  a  single determinant  (e.g.,  arsenobenzoate-N-acetyl tyro- 
sine),  or is  a macromolecular antigen that is quickly phagocytosed and frag- 
mented by the hydrolases of macrophages that have been activated as by myco- 
bacterial adjuvant,  then  the  thymus-derived recognition cells  would be con- 
cerned in the response, while the potential antibody-synthesizing entities would 
not become involved. Obviously, there would usually be intermediate situations 
in which both responses could occur. 
One may question why,  in  the  animal,  the  use of mycobacterial adjuvant 
often  results  in  good  antibody synthesis  as  well  as  delayed reactivity.  The 
answer may lie in the distribution of cellular areas influenced by the lipoidal 
mycobacterial-activating substance.  Water-soluble antigens  may quickly dis- 
seminate  to  lymphoid  tissues  beyond  the  reach  of  this  substance  to  induce 
antibody production. 
SUMMARY 
Sheep erythrocytes ingested by guinea pig peritoneal macrophages in vitro, 
and permitted to undergo digestion for various periods, were found after some 
hours to lose the capacity to induce antibodies while gaining the ability to in- 
voke delayed hypersensitivity. These observations may be related to the known 
predilection of small molecular immunogens to act as good inducers of delayed 
reactivity and poor stimulators of antibody. They may be related also to the 
activity of mycobacterial adjuvant  as  a  vehicle for the  induction of delayed 
hypersensitivity  on  the  basis  that  this  melange  activates  macrophages  to 
phagocytose and enzymatically degrade macromolecular antigens rapidly. The 
thesis  that  small fragments of antigenic molecules may preferentially invoke 504  IVIACROPHAGE-DIGESTED  ANTIGEN 
hypersensitivity can be interpreted on  the  basis  of current  concepts  of multi- 
cellular involvements in immune responses. 
BIBLIOGRAPHY 
1.  Jones, V.  E., and S. Leskowitz.  1965. Role of the carrier in development of de- 
layed sensitivity to the azophenyl-arsonate group. Nature  (London). 9.07:596. 
2.  Stupp, Y., F. Borek, and M. Sela.  1966. Studies on the types of immune responses 
to synthetic antigens in guinea pigs.  Immunology. 11:561. 
3.  Benacerraf, B., and P. G. H. Gell.  1959. Studies on hypersensitivity. I. Delayed 
and  Arthus-type skin reactivity to protein conjugates in guinea pigs.  Immu- 
nology. 2:53. 
4.  Maurer,  P.  H.  1961. Immunologic studies  with  ethylene  oxide-treated  human 
serum. J. Exp. Med. 113:1029. 
5.  Salvin,  S.  B.,  and  H.-L.  Liauw.  1967.  Hypersensitivity  to peptide  fragments. 
Int. Arch. Allergy Appt. Immund. 31"366. 
6.  Landsteiner,  K.  1962. The Specificity of Serological  Reactions.  Dover Publica- 
tions Inc., New York. 200. 
7.  Eisen, H. N., and S. Belman.  1953. Studies of hypersensitivity to low molecular 
weight substances. II. Reactions of some allergenic substituted dinitrobenzenes 
with cysteine or cystine of skin proteins. J. Exp. Mecl. 98:533. 
8.  Raffel,  S.  1948. The  components  of  the  tubercle  bacillus  responsible  for  the 
delayed type of "infectious" allergy. J. Infec. Dis. 82:267. 
9.  White, R. G.  1965. The role of peptido-glycolipids of M. tuberculosis and related 
organisms  in  immunological  adjuvance.  IN Molecular  and  Cellular  Basis  of 
Antibody Formation. J.  Sterzl,  ed.  Academic Press, Inc., New York. 71. 
10.  Lurie, M. B.  1964. Resistance to Tuberculosis: Experimental  Studies  of Native 
and Acquired Defensive Mechanisms.  Harvard  University Press,  Cambridge, 
Mass. 77. 
11.  Dannenberg,  A.  M.  1968. Cellular  hypersensitivity  and  cellular  immunity  in 
the  pathogenesis  of  tuberculosis:  Specificity,  systemic  and  local nature,  and 
associated  macrophage  enzymes.  Bacteriol. Rev. 32:85. 
12.  Miller,  J. F. A. P., and G. F. Mitchell.  1969. Thymus and antigen-reactive cells. 
Transplant. Rev. 1:3. 
13.  Claman,  H. N.,  and E.  A.  Chaperon.  1969. Immunologic complementation be- 
tween thymus and marrow cells--A model for the two-cell theory of immuno- 
competence. Transplant. Rev. 1:92. 
14.  Taylor, F. B.  1969. Cellular cooperation in the antibody response of mice to two 
serum  albumins:  Specific  function  of  thymus  cells.  Transplant.  Rev. 1:114. 
15.  Williams,  R. M., and B. H. Waksman.  1969. Thymus-derived cells in the early 
phase of delayed tuberculin reactions. J. Immunol.  103:1435. 
16.  Boyden, S.  V.  1964. Cytophilic antibody in guinea pigs with  delayed-type hy- 
persensitivity. Immunology. 7"474. 
17.  Gerety, R.  J.,  R. W.  Ferraresi,  and  S.  Raffel.  1970.  Polysaccharide in  delayed 
hypersensitivity.  I.  Pneumococcal polysaccharide  as  inducer  and  elicitor  of 
delayed reactivity in guinea pigs. J. Exp. Med. 131:189. 
18.  Messina, V. P.,  and L. T. Rosenberg.  1962. Enhancement by normal cells of an 
immunological response. Proc. Soc. Exp. Biol. ivied. 110:893. MARGOT N.  PEARSON AND SIDNEY RAFFEL  505 
19.  Cohn, Z. A. 1964. The fate of bacteria within phagocytic cells. III. Destruction of 
an  Escherichia coli agglutinogen  within  polymorphonuclear  leukocytes  and 
macrophages. J. Exp. Med. 19.0:869. 
20.  Unanue,  E.  R.  1968. The immune response of mice to I(eyhold Limpet hemo- 
cyanin bound to macrophages. J. Immunol.  102:893. 
21.  Perkins, E. H., and T. J. Makinodan.  1965. The suppressive role of mouse peri- 
toneal phagocytes in agglutinin response. J. Immunol. 9~h765. 
22.  Morita, T., and E. H. Perkins.  1965. A simple quantitative method to assess  the 
in vitro engulfing and  degradative potentials  of mouse peritoneal  phagocytic 
cells. J. Reticuloendothet. Soc. 2:406. 
23.  Argyris,  B.  F.  1967.  Role  of  macrophages  in  antibody  production.  Immune 
response to sheep red blood cells. J. Immunol.  99:744. 
24.  Mitchison, N. A. 1969. The immunogenic capacity of antigen taken up by peri- 
toneal exudate cells. Immunology. 16:1. 
25.  Unanue, E. R., and B. A. Askonas. 1968. Persistence of immunogenicity of anti- 
gen after uptake by macrophages. J..Exp. Med. 127:915. 
26.  Unanue, E. R., and B. A. Askonas. 1968. The immune response of mice to anti- 
gen in macrophages. Immunology. 15:287. 
27.  Cohn, Z. A., and E. Wiener. 1963. The particulate hydrolases of macrophages. I. 
Comparative  enzymology, isolation,  and  properties,  d.  Exp.  Med.  118:991. 
28.  Ferraresi, R. W., C. T. Dedrick, S. Raffel, and  M. Goihman-Yahr. 1969. Studies 
of the macrophage inhibition test. I. Comparison of the skill and cell migration 
reactions  during  the  course  of  development  of  delayed  hypersensitivity.  J. 
Immunol. 102:852. 